The PRPF31 gene helps cells process genetic messages so they can make the proteins they need, especially in the retina, the light sensing tissue at the back of the eye. This gene plays an important role in keeping retinal cells working over time. If you carry a pathogenic variant in the PRPF31 gene, the retina may gradually lose function, which can lead to retinitis pigmentosa with night blindness, reduced side vision, and later changes in central vision. Some people with a PRPF31 gene variant have clear symptoms, while others have few or none.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or guide activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others are mainly involved in regulating when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you react to food, stress, or medicines. For a deeper look at this subject, you can find more in the LearnHub.
Overview
PRPF31Gene function
What if the gene works
The PRPF31 gene helps cells splice RNA, an editing step that turns early genetic messages into working instructions for proteins. This process is especially important for light-sensing cells in the retina.
Risk
What if the gene does not work
Variants in the PRPF31 gene are linked to retinitis pigmentosa, an inherited eye condition. People may develop night blindness and side vision loss, with onset and severity varying; milder and more severe variants can affect how much vision changes.
Treatment
What does that mean for your treatment
No PRPF31-specific treatment or drug selection approach is currently established for people with a pathogenic or loss-of-function variant in the PRPF31 gene. The PRPF31 gene is being studied as a target for inherited retinal disease therapies, including gene-based approaches in early-stage research.
Conditions associated with PRPF31
Gene function
What if the gene works
Your cells need the PRPF31 gene to turn fresh RNA messages into usable instructions. It helps edit these messages before the cell makes proteins. Understanding how the PRPF31 gene works in cells helps explain how routine gene activity stays organized across the body.
The PRPF31 gene helps your cells edit newly made RNA messages. It removes extra sections and joins the useful parts so the message is ready to guide protein making.
Inside the cell's RNA editing machine, this gene helps key parts come together in the right place. That support keeps the splicing process orderly and efficient.
By supporting careful RNA processing, this gene helps many cells prepare accurate instructions for making proteins. This steady work supports normal daily cell activity across the body.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How PRPF31 gene variants affect RNA splicing often comes down to too little working PRPF31 protein in the cell. Nonsense, frameshift, splice-site, and whole-gene variants usually stop production early, while some missense variants make the protein unstable or less able to work with partner proteins. These changes can be mild or more severe, and a larger loss of function is often linked to earlier or more marked retinitis pigmentosa.
How variants are linked to conditions
Pathogenic variants in the PRPF31 gene are a well-established cause of PRPF31-related retinitis pigmentosa, an inherited eye condition that can lead to night blindness, narrowing side vision, and gradual vision loss. This usually runs in families in an autosomal dominant pattern. Some people who carry a disease-causing variant have clear symptoms, while others in the same family may have milder changes or no noticeable symptoms.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PRPF31, risk is shaped mainly by the variant itself and by how active the healthy copy of the gene is, which can help explain why some family members develop vision loss and others do not. There is not enough evidence to say that lifestyle changes lower this risk.
Inheritance of PRPF31 variants
PRPF31-related disease is usually inherited in an autosomal dominant pattern, which means one altered copy of the PRPF31 gene can be enough to run in a family. A parent carrying the variant has a 50% chance of passing it to each child, and it can be inherited from either the mother or the father. In PRPF31 gene inheritance, an important detail is reduced penetrance, so some people who carry the variant may never develop symptoms but can still pass it on to their children.
What does my PRPF31 result mean for my family?
PRPF31 results are most often linked to an inherited eye condition called retinitis pigmentosa that usually runs in families in a dominant pattern. This means close relatives, including parents, brothers, sisters, and children, may also carry the same gene change and may want to learn whether it is present in them. In some families, someone can carry a PRPF31 change and have few or no symptoms, so a family history may not always look obvious.
Genetic information
Genetic testing
How you find out about variants
PRPF31 genetic testing uses a blood or saliva sample to look for changes in the PRPF31 gene linked to inherited retinal disease. A lab reads the DNA sequence and may also check for missing or extra pieces of the gene, with results reported as a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the PRPF31 gene may be worth considering if you or close relatives have inherited vision loss, especially night blindness, narrowing side vision, or retinitis pigmentosa. It can help confirm whether PRPF31 is the cause and clarify family risk.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body absorbs, breaks down, or responds to medicines. This helps explain why the same treatment works well for one person, causes more side effects in another, or seems to have less effect in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It studies gene-drug relationships to help explain why the same treatment may work differently in different people. With many medications, genes can influence either how strongly a medicine works or how the body handles it. Understanding this can support treatment choices that are more informed and more personalized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the PRPF31 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how the body responds to medicines. Questions about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor or pharmacist.
History
PRPF31 entered the medical literature as researchers worked to explain inherited forms of retinitis pigmentosa, a condition that affects vision over time. In the late 1990s and early 2000s, advances in genetics gradually revealed how this gene works, linking PRPF31 variants to autosomal dominant retinitis pigmentosa in some families. Its history became especially important because families with the same gene change could show very different patterns of vision loss, including people who carried the variant but had few or no symptoms. That observation pushed researchers to think more carefully about why inherited eye conditions do not always look the same from one person to another. From these first observations, research expanded steadily. PRPF31 is now recognized as part of the broader story of how retinal genetics developed into a more precise field.